Vimarsana
Biggest News Aggregation in the World

Page 5 - Diagnostics Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Development Today - Breaking & Trending Today

NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay - Vimarsana News

NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay

25.04.2022 - FT. MYERS, FL / ACCESSWIRE / April 25, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today that they are partnering with Eli Lilly and ... Seite 1

Biomarkers Market Recent Industry Developments and Growth Strategies Adopted by Top Key Players Enzo - Vimarsana News

Biomarkers Market Recent Industry Developments and Growth Strategies Adopted by Top Key Players Enzo

New York, (18-01-2022) –  Biomarkers Market document provides complete background analysis of the industry which includes an assessment of the parental market. Competitor analysis is one of the most imperative aspects of market research report which helps businesses decide upon the strategies by comparing them with...

Singapore enhances neutralizing antibody testing service - Vimarsana News

Singapore enhances neutralizing antibody testing service

Singapore enhances neutralizing antibody testing service Singapore enhances neutralizing antibody testing service 12 April 2021 | News Image credit- prnewswire GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway's panel of specialist and GP clinics. Neutralizing antibodies are a small percentage of antibodies that bind to sites on the virus and inhibit entry of that virus into the host. Unlike the many COVID-19 lab-based antib...

New partnership to develop test for predicting disease course in pediatric Crohn's patients - Vimarsana News

New partnership to develop test for predicting disease course in pediatric Crohn's patients

New partnership to develop test for predicting disease course in pediatric Crohn's patients The Crohn's & Colitis Foundation, the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD), has entered into a partnership with LifeArc, an independent medical research charity that advances translation of early science into health care treatments or diagnostics, to potentially develop the first clinical lab test to predict disease course in pediatric patients with Crohn's disease and response to treatment. A prognostic test which could accur...

Covid-19 saliva test kit developed in Singapore ready for use - Vimarsana News

Covid-19 saliva test kit developed in Singapore ready for use

December 14, 2020 Patients have to draw saliva from deep within their throats which they then spit into a specimen bottle. A*Star SINGAPORE - Instead of nasal swabs, those who need to be tested for Covid-19 in Singapore may soon have the option of offering their saliva sample, following the development of a test kit here. The Resolute 2.0 kit was developed by the Agency for Science, Technology and Research's (A*Star) Diagnostics Development (DxD) Hub and DSO National Laboratories in July. While it allows for tests using nasal swabs, the kits also facilitate Covid-19 testing using saliva. Pati...